#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Chordoma Glioma Burkitt's lymphoma Severe myoclonic epilepsy of infancy Cerebral amyloid angiopathy Fatty acid oxidation disorder Chronic myelomonocytic leukaemia Alport's syndrome Biotinidase deficiency Neuronal ceroid lipofuscinosis Breast cancer Synovial sarcoma recurrent Immune-mediated renal disorder Obliterative bronchiolitis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Diagnostics Nodal marginal zone B-cell lymphoma – Life with Disease Alternating hemiplegia of childhood – Diagnostics Cystic fibrosis lung – Diagnostics Angiosarcoma – Diagnostics Prader-Willi syndrome – Basic Information Friedreich’s ataxia – Life with Disease Splenic marginal zone lymphoma – Basic Information Primary mediastinal large B-cell lymphoma – Life with Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brexucabtagene Autoleucel Sodium Butyrate Efepoetin Alfa Ecoo1A Venlafaxine Hydrochloride Xenon (129Xe) Granisetron Naloxegol Oxalate Oxygen Ph.eur. Keto-Isoleucine Calcium Incb000928 Levofloxacin Lutetium (177Lu) Edotreotide CEFTAROLINE FOSAMIL Padeliporfin Paltusotine Fianlimab Mepolizumab Gebasaxturev F125/10 More therapies…

    Learn about Your Condition

    Decreased appetite Adenocarcinoma pancreas Proteinuria Undifferentiated sarcoma Hypertension Transient ischaemic attack Endometrial cancer stage III Staphylococcal infection Neurodevelopmental disorder Cervix carcinoma stage I Lymphoma Immune system disorder Migraine Adenocarcinoma Keratosis follicular More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Ursodeoxycholic Acid to Prevent Recurrence of Acute Biliary Pancreatitis in Patients After Gallstone-Related Episode

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive pancreatitis
    • Pancreatitis acute
    Investigated Drugs:
    • Ursodeoxycholic Acid
    Spain

  • Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Autologous Cord Blood-Derived Dendritic Cells Loaded With Wt1 Peptide Pool
    The Netherlands

  • Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Umbilical Cord-Derived Cd34- Cells, Non-Expanded
    • Dorocubicel
    The Netherlands

  • Study on Pembrolizumab, Atezolizumab, and Nivolumab with Carbon Ion Radiotherapy for Patients with Advanced Melanoma, Urothelial Carcinoma, NSCLC, or Head & Neck Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Atezolizumab
    • Cemiplimab
    • Nivolumab
    Italy

  • Study of KYV-101, Fludarabine Phosphate, and Cyclophosphamide Monohydrate for Patients with Treatment-Resistant ANCA Vasculitis

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Kyv-101
    • Fludarabine Phosphate
    Germany

  • Study Comparing Intranasal Nafarelin and Subcutaneous Triptorelin for Final Egg Maturation in Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Nafarelin
    • Triptorelin
    Spain
Previous Page
1 … 842 843 844 845 846 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!